Security key
74373P108
PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (PVCT)
CUSIP: 74373P108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 228,811
- Total 13F value
- $28,570
- Share change
- 0
- SEC-reported price per share
- $0.13
- Number of holders
- 6
- Shares outstanding
- 451,690,568
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
6
Top holders
6
PVCT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
PROVECTUS BIOPHARMACEUTICALS, INC. SEC filings
PROVECTUS BIOPHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74373P108
Recent filing periods:
Ownership snapshot
Top reported holders of PVCT - PROVECTUS BIOPHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HOME FEDERAL BANK OF TENN...
Disclosed value leader
HOME FEDERAL BANK OF TENN...
Comparable rows
5/6
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 0.02%
1 rows are not safely comparable across share classes.
Quick read
HOME FEDERAL BANK OF TENNESSEE leads the comparable SEC ownership view at 0.02%.
5 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HOME FEDERAL BANK OF TENNESSEE's linked filing trail.
Comparable ownership
Top 5
HOME FEDERAL BANK OF TENNESSEE
0.02%
Atlas Wealth LLC
0.01%
LBMC INVESTMENT ADVISORS, LLC
0%
ACADEMY CAPITAL MANAGEMENT
0%
Financial Symmetry Inc
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE |
13F
Company
|
0.02%
|
$18,300
100,000 shares
|
— | 31 Mar 2024 |
| Atlas Wealth LLC |
13F
Company
|
0.01%
|
$4,866
26,620 shares
|
— | 31 Mar 2024 |
| LBMC INVESTMENT ADVISORS, LLC |
13F
Company
|
0%
|
$4,024
22,000 shares
|
— | 31 Mar 2024 |
| ACADEMY CAPITAL MANAGEMENT |
13F
Company
|
0%
|
$3,657
20,000 shares
|
— | 31 Mar 2024 |
| Financial Symmetry Inc |
13F
Company
|
0%
|
$1,863
10,191 shares
|
— | 31 Mar 2024 |
| Bruce Horowitz |
3/4/5
COO, Director
|
—
class O/S missing
|
—
38,473 shares
|
— | 17 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
228,811
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
5
Q2 2024 holders
6
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend